Self-expanding interposed member spacing protective sleeve from restenosis restraining agent coated balloon catheter

• US 9,616,202 B2
• Filed: 10/25/2013
• Issued: 04/11/2017
• Est. Priority Date: 07/25/2011
• Status: Active Grant

• Current Assignee: Terumo Kabushiki Kaisha
• Original Assignee: Terumo Kabushiki Kaisha
• Inventors: Osada, Toshihiko, Kinoshita, Yasushi, Kasukawa, Hiroaki, Yamashita, Keiko
• Primary Examiner(s): Gilbert, Andrew
• Assistant Examiner(s): Engel, Matthew A
• Application Number:
  US14/063,576
• Publication Number:
  US 20140052104A1
• Time in Patent Office: 1,264 Days
• Field of Search: 604 9601, 604 9701- 9703, 604 22, 6048901, 60410102
• CPC Class Codes: A61M 2025/0183 Rapid exchange or monorail catheters
• CPC Class Codes: A61M 2025/09125 Device for locking a guide wire in a fixed position with respect to the catheter or the human body
• CPC Class Codes: A61M 2025/105 having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
• CPC Class Codes: A61M 2025/1081 having sheaths or the like for covering the balloon but not forming a permanent part of the balloon, e.g. retractable, dissolvable or tearable sheaths
• CPC Class Codes: A61M 25/1002 characterised by balloon shape A61M25/1006, A61M25/1009 take precedence
• CPC Class Codes: A61M 25/104 used for angioplasty

Abstract

A treatment device includes: a balloon; a biologically active agent part applied on an outer surface of the balloon; a protective sleeve encircling the balloon and being displaceable proximally; and an interposed member having a self-expanding function arranged between the balloon and the protective sleeve. When the protective sleeve is moved proximally in order for the balloon to be exposed to the inside of a blood vessel, the presence of the interposed member prevents the biologically active agent part from being scraped and peeled off by the inner surface of the protective sleeve.

Claims

1. A treatment device comprising:

a device body having a shaft;

an inflatable balloon disposed at a distal portion of the shaft, the inflatable balloon possessing an outer surface;

a biologically active agent on the outer surface of the inflatable balloon and containing at least one biologically active agent;

a protective sleeve covering the biologically active agent and displaceable proximally in relation to the device body;

an interposed member having a self-expanding function and disposed between the inflatable balloon and the protective sleeve in surrounding relation to the inflatable balloon, the entirety of the interposed member disposed between the inflatable balloon and the protective sleeve having the self-expanding function, and the interposed member is displaceable proximally in relation to the device body to be completely retracted from the inflatable balloon, so that when the inflatable balloon expands the biologically active agent on the outer surface of the inflatable balloon directly contacts a target site and the inflatable balloon does not contact the interposed member; and

the interposed member expanding, while still surrounding the inflatable balloon, when the protective sleeve is displaced proximally.

2. The treatment device according to claim 1, further comprising an operating mechanism fixed to a proximal end of the interposed member so that the interposed member moves together with the operating mechanism, the operating mechanism extending along the shaft at least to a proximal end side of the device body, the operating mechanism being configured to inhibit the interposed member from moving proximally relative to the inflatable balloon during proximal displacement of the protective sleeve, and the operating mechanism being configured to displace the interposed member proximally upon operation on the proximal end side of the device body.

3. The treatment device according to claim 2, wherein the interposed member and the operating mechanism are integrally formed so that the interposed member and the operating mechanism constitute a common member.

4. The treatment device according to claim 2, wherein the operating mechanism is a tube extending along the shaft to a proximal portion of the shaft.

5. The treatment device according to claim 2, wherein the operating mechanism includes a linear member extending along the shaft.

6. The treatment device according to claim 5, wherein the operating mechanism is detachably fixed to the device body by a fixing mechanism.

7. The treatment device according to claim 6, wherein the fixing mechanism is disposed at a proximal portion of the device body.

8. The treatment device according to claim 7, wherein the fixing mechanism includes a first clamping part on the device body and a second clamping part configured to engage and be disengaged from the first clamping part, and the operating mechanism is fixed by clamping the operating mechanism between the first clamping part and the second clamping part.

9. A treatment device positionable in a blood vessel of a living body to treat a stenosed region, the treatment device comprising:

an elongated shaft possessing a distal portion;

an inflatable balloon fixed to the distal portion of the elongated shaft so that the inflatable balloon and the elongated shaft move together, the inflatable balloon possessing an outer surface and an interior;

a flow path inside the elongated shaft that communicates with the interior of the inflatable balloon and through which fluid is introduced into the interior of the inflatable balloon to inflate and outwardly expand the inflatable balloon;

a restenosis-restraining biologically active agent on the outer surface of the inflatable balloon that restrains restenosis, the restenosis-restraining biologically active agent being applied to the stenosed region of the blood vessel when the inflatable balloon is inflated and outwardly expanded into contact with the stenosed region;

a protective sleeve covering an entirety of the outer surface of the inflatable balloon having the restenosis-restraining biologically active agent, the protective sleeve possessing an inner surface and being axially movable in a proximal direction relative to the elongated shaft;

a cylindrically shaped interposed member positioned radially between the protective sleeve and the restenosis-restraining biologically active agent to space the protective sleeve from the restenosis-restraining biologically active agent and prevent the restenosis-restraining biologically active agent from contacting the protective sleeve both before the treatment device is delivered to the stenosed region and when the treatment device is at the stenosed region, the entirety of the cylindrically shaped interposed member that is positioned radially between the protective sleeve and the restenosis-restraining biologically active agent possessing a self-expanding function in which the cylindrically shaped interposed member expands radially outwardly when the protective sleeve is axially moved in the proximal direction relative to the cylindrically shaped interposed member, and the cylindrically shaped interposed member is configured to be completely retracted from the inflatable balloon to allow the restenosis-restraining biologically active agent on the outer surface of the inflatable balloon to directly contact the stenosed region when the inflatable balloon is expanded; and

the cylindrically shaped interposed member and the restenosis-restraining biologically active agent on the outer surface of the inflatable balloon being configured to contact one another when the treatment device is moved in the living body towards the stenosed region while the cylindrically shaped interposed member is positioned radially between the protective sleeve and the restenosis-restraining biologically active agent.

10. The treatment device according to claim 9, wherein the cylindrically shaped interposed member is a wound coil.

11. The treatment device according to claim 9, further comprising a linear operating member fixed to the cylindrically shaped interposed member so that the cylindrically shaped interposed member moves together with the linear operating member, the linear operating member extending proximally along the elongated shaft at least to a proximal end of the elongated shaft.

12. The treatment device according to claim 11, wherein the cylindrically shaped interposed member and the linear operating member are integrally formed so that the cylindrically shaped interposed member and the linear operating member constitute a common member.

13. The treatment device according to claim 11, further comprising a fixing mechanism that detachably fixes the linear operating member relative to the elongated shaft so that the linear operating member is fixed in position relative to the elongated shaft.

14. The treatment device according to claim 13, wherein the fixing mechanism is disposed at a proximal portion of the elongated shaft.

15. The treatment device according to claim 13, wherein the fixing mechanism includes a first clamping part fixed to the elongated shaft and a second clamping part configured to engage and be disengaged from the first clamping part, the linear operating member being fixed relative to the elongated shaft by being clamped between the first clamping part and the second clamping part.

16. The treatment device according to claim 9, further comprising a cylindrical operating member fixed to the cylindrically shaped interposed member so that the cylindrically shaped interposed member moves together with the cylindrical operating member, the cylindrical operating member extending proximally beyond a proximal-most end of the protective sleeve.

17. The treatment device according to claim 16, wherein the cylindrical operating member possesses a proximal end connected to a hub so that axial movement of the hub results in axial movement of the cylindrical operating member, the hub being axially movable relative to the elongated shaft.

18. The treatment device according to claim 16, wherein the cylindrically shaped interposed member and the cylindrical operating member are integrally formed so that the cylindrically shaped interposed member and the cylindrical operating member constitute a common member.

19. The treatment device according to claim 9, wherein the cylindrically shaped interposed member possesses an inner surface spaced from the restenosis-restraining biologically active agent so that an annular gap exists between the inner surface of the cylindrically shaped interposed member and the restenosis-restraining biologically active agent.